Medtronic’s Prestige LP Cervical Disc receives 2-level FDA approval: 6 things to know

The FDA cleared Medtronic’s Prestige LP Cervical Disc for two-level applications.

Advertisement

Here are six things to know:

 

1. The device is cleared for the treatment cervical disc disease treatment at two adjacent levels between the C3-C7 segments.

 

2. The device is Medtronic’s third artificial cervical disc and Medtronic’s first disc determined safe and effective for both one- and two-level procedures. LDR’s Mobi-C is also cleared for two-level disc replacement.

 

3. The device has a low profile and a ball-and-trough design.

 

4. Early in May, Medtronic released results of a seven-year follow-up study in which the two-level Prestige LP Cervical Disc was compared to two-level anterior cervical discectomy and fusion.

 

5. The follow-up study showed that two-level Prestige LP Disc patients showed greater rates in overall success (78.6 percent) compared to the patients treated with two-level ACDF (62.7 percent).

 

6. There are a few risks associated with the device including, but not limited to, the development of new nerve or spinal cord compression or pain.

 

More articles on devices:
Dr. Nicole Ehrhart’s preclinical study affirms AlloStem Cellular Bone Allograft effectiveness: 5 key takeaways
Safe Orthopaedics names Pierre Dumouchel CEO: 3 things to know
Aurora Spine receives $1M insider loan: 4 notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.